Inscripta is a company that develops a benchtop platform for scalable digital genome engineering. The company’s CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables trackable editing of single cells. Inscripta’s goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations.